Suppr超能文献

儿童长期抗菌治疗期间的不良反应。

Adverse reactions in children during long-term antimicrobial therapy.

作者信息

Uhari M, Nuutinen M, Turtinen J

机构信息

Department of Pediatrics, University of Oulu, Finland.

出版信息

Pediatr Infect Dis J. 1996 May;15(5):404-8. doi: 10.1097/00006454-199605000-00005.

Abstract

BACKGROUND

It is difficult to obtain reliable date on the rate of adverse reactions caused by drugs in general use. Yet it would be important to compile data on adverse reactions to long-term antimicrobial therapy.

METHODS

A sample of 1607 girls and 218 boys from 16 409 children younger than 16 years who had received long term antimicrobial therapy for recurrent urinary tract infections during 1976 to 1985 was analyzed with regard to adverse reactions.

RESULTS

Altogether 5066 courses of treatment were given to female patients and 607 to male patients. Adverse reactions were reported in 589 courses of the 5673 (10.4%), and 463 courses (8.2%) were discontinued because of adverse reactions. None of the patients had serious life-threatening reactions, and none of those receiving nitrofurantoin had pulmonary problems. The most common adverse reactions associated with the use of nitrofurantoin were nausea and vomiting (rate, 4.4/100 person years at risk; 95% confidence interval, 3.4 to 5.4), whereas sulfonamides caused most commonly allergic skin reactions (rate, 4.6; 95% confidence interval, 3.2 to 6.5). Patients younger than the age of 2 years receiving nitrofurantoin had adverse reactions more often than those who received sulfonamides, but in the age group 2 to 15 years sulfonamides caused adverse reactions leading to discontinuation of treatment more often than did nitrofurantoin of treatment the adverse reactions occurred during the first 6 months of treatment.

CONCLUSIONS

We found nitrofurantoin and sulfonamides to be safe drugs for use in long term preventive antimicrobial therapy.

摘要

背景

获取常用药物不良反应发生率的可靠数据存在困难。然而,汇编长期抗菌治疗不良反应的数据却很重要。

方法

对1976年至1985年间因复发性尿路感染接受长期抗菌治疗的16409名16岁以下儿童中的1607名女孩和218名男孩的样本进行不良反应分析。

结果

女性患者共接受了5066个疗程的治疗,男性患者接受了607个疗程。在5673个疗程中有589个(10.4%)报告了不良反应,463个疗程(8.2%)因不良反应而停药。没有患者出现严重的危及生命的反应,接受呋喃妥因治疗的患者也没有出现肺部问题。与使用呋喃妥因相关的最常见不良反应是恶心和呕吐(发生率,4.4/100人年风险;95%置信区间,3.4至5.4),而磺胺类药物最常引起过敏性皮肤反应(发生率,4.6;95%置信区间,3.2至6.5)。接受呋喃妥因治疗的2岁以下患者比接受磺胺类药物治疗的患者更常出现不良反应,但在2至15岁年龄组中,磺胺类药物导致因不良反应停药的情况比呋喃妥因更常见。不良反应发生在治疗的前6个月。

结论

我们发现呋喃妥因和磺胺类药物是长期预防性抗菌治疗中安全的药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验